Form 4 for ASBP Aspire Biopharma Holdings, Inc.
Accepted 2023-05-30 00:00:00 ET · period of report 2023-05-18 · accession 0001104659-23-065925 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-30 | 2023-05-18 | ASBP | PowerUp Sponsor LLC | 10% | C - Cnv Deriv | — | +7.19M | 7.19M | New | — |
| D | 2023-05-30 | 2023-05-18 | ASBP | PowerUp Sponsor LLC | 10% | C - Cnv Deriv | — | -7.19M | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Shares, par value $0.0001 | 2023-05-18 | C | A | 7,187,500 | — | 7,187,500 | D | — | — | (F1) On May 18, 2023, the Reporting Person elected to convert the 7,187,500 Class B ordinary shares ("Class B Shares") of PowerUp Acquisition Corp. (the "Issuer") held by the Reporting Person into Class A ordinary shares of the Issuer ("Class A Shares") on a one-for-one basis. As a result, 7,187,500 of the Class B Shares were cancelled, and 7,187,500 Class A Shares were issued to the Reporting Person on May 18, 2023. |
| 2 | Derivative | Class B Ordinary Shares | 2023-05-18 | C | D | 7,187,500 | — | 0 | D | — · — to — | 7,187,500 Class A Ordinary Shares | (F1) On May 18, 2023, the Reporting Person elected to convert the 7,187,500 Class B ordinary shares ("Class B Shares") of PowerUp Acquisition Corp. (the "Issuer") held by the Reporting Person into Class A ordinary shares of the Issuer ("Class A Shares") on a one-for-one basis. As a result, 7,187,500 of the Class B Shares were cancelled, and 7,187,500 Class A Shares were issued to the Reporting Person on May 18, 2023. |